Recent Quotes (30 days)

You have no recent quotes
chg | %

Alere Inc  

(Public, NYSE:ALR-B)   Watch this stock  
Find more results for ALR-B
233.75
0.00 (0.00%)
Jun 18 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 182.87 - 255.87
Open     -
Vol / Avg. 0.00/5,248.00
Mkt cap 2.08B
P/E     -
Div/yield     -/5.13
EPS -1.09
Shares 8.90M
Beta 1.28
Inst. own 804%
Aug 5, 2013
Q2 2013 Alere Inc Earnings Release Add to calendar
Jun 13, 2013
Alere Inc at Goldman Sachs Healthcare Conference
Jun 4, 2013
Alere Inc at Jefferies Global Healthcare Conference
May 14, 2013
Alere Inc Annual Shareholder Meeting
May 9, 2013
Q1 2013 Alere Inc Earnings Conference Call
May 6, 2013
Q1 2013 Alere Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 1.28% -3.23%
Operating margin 4.12% 3.86%
EBITD margin - 21.14%
Return on average assets 0.53% -1.33%
Return on average equity 1.87% -6.22%
Employees 17,400 -
Carbon Disclosure Rating - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�s segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Officers and directors

Ron Zwanziger Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 48
Bio & Compensation  - Reuters
Michael Lester Cotton President and Chief Executive Officer of Alere Health, LLC
Age: 50
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President, Europe and Middle East
Age: 48
Bio & Compensation  - Reuters
James Post President of Alere North America, Inc.
Age: 49
Bio & Compensation  - Reuters
David Toohey President - International Business Operations
Age: 55
Bio & Compensation  - Reuters
David Walton President, Asia Pacific
Age: 58
Bio & Compensation  - Reuters
Namal Nawana Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Paul T. Hempel Senior Vice President - Ethics/Compliance, Special Counsel, Assistant Secretary
Age: 63
Bio & Compensation  - Reuters
Jerry McAleer Ph.D. Senior Vice President - Research and Development, Director
Age: 56
Bio & Compensation  - Reuters